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Opinion statement 
Environmental contamination is being increasingly recognized as a significant source of 
healthcare-associated infection (HAI).  Cross-contamination of the patient from the 
environment can result from the direct transfer of organisms from the air and surfaces, 
or indirectly from the hospital environment via contact with healthcare workers or 
equipment.  Traditional methods of environmental decontamination, including cleaning 
with disinfectants, and the standard infection control procedures implemented by 
modern Health Services, are critical to controlling the spread of potentially pathogenic 
microbial contaminants from environmental sources to the patient; however there is 
constant pressure to maintain, and indeed, improve on the standards that are in place to 
ensure optimal patient care.  To address this issue, much research has been directed 
towards the development and testing of novel ěZKROH-URRPĜ environmental 
decontamination methods which could be used to enhance hospital hygiene, and 
consequently reduce the risk of HAI-acquisition from environmental sources.  Gaseous 
methods such as the use of hydrogen peroxide, chlorine dioxide, ozone and steam, as 
well as ultraviolet and violet-blue visible light methods have all been laboratory tested, 
and to varying extents, clinically evaluated to assess their efficacy for environmental 
decontamination.  This review article considers these different decontamination 
technologies, discussing their mechanism of action, antimicrobial efficacy, and 
advantages and limitations, with a view to providing the reader with a comprehensive 
overview of the technological advances being developed to reduce the levels of 
environmental contamination around patient areas, thus aiding in the fight against 
healthcare-associated infection. 
 
1. The Importance of Environmental Decontamination 
Microbiological contamination of the clinical environment is increasingly being highlighted as a source of infection, with direct 
contact with contaminated surfaces, indirect contact with contaminated surfaces via the hands of medical staff or equipment, and 
the air, all being recognised as potential sources of cross-infection [1-3]. High standards of cleaning and disinfection will 
contribute to minimising the risk of infection, and have been shown to play an important role in controlling outbreaks of infection 
[4,5].  
The hospital environment can quickly become contaminated and act as a reservoir for infection, and evidence shows that 
VLJQLILFDQWFRQWDPLQDWLRQRIQXUVH¶VKDQGVFDQRFFXUIURPFRQWDFWZLWKHQYLURQPHQWDOVXUIDFHVLQWKHSDWLHQW¶VHQYLURQPHQW>2, 6-
8].  Frequently-touched sites, such as door handles, light switches, bed tables and bed rails, are thought to provide the greatest 
potential risk for cross-infection [9].  Previous studies have demonstrated that healthcare workers hands can become contaminated 
through contact with inanimate objects or intact patient skin surfaces, and they can subsequently transfer organisms to other 
surfaces within the room, and potentially to other patients [7].  Indeed, healthcare workers are almost as likely to contaminate 
their hands after only touching environmental surfaces in the room as they are when they touch both the patient and 
environmental surfaces [8]. 
Environmental cleaning using disinfectants is essential for reducing contamination, however ensuring that the level of cleaning 
which occurs is adequate can be an issue.  Studies have shown that flat surfaces such as bedside tables and locker tops, are 
cleaned more often than small vertical surfaces such as door handles and light switches [10,11], but also, there are surfaces within 
the room, such as walls and electronic equipment, which are not routinely cleaned but can still harbour potential pathogens.  
Another issue is that there can be uncertainty amongst staff about who has responsibility for cleaning patient-related surfaces and 
medical equipment [9,10].  In addition to these difficulties, organisms such as MRSA, C. difficile, Acinetobacter and 
vancomycon-resistant enterococci (VRE) can persist on surfaces in the hospital environment ± even after discharge cleaning ± for 
significant periods of time, facilitating their transmission between patients, staff and the environment [9,12]. 
As a consequence of these issues, there has been an upsurge of interest in the development of new µZKROH-URRP¶environmental 
decontamination technologies [12,13,14] which can supplement the standard cleaning and infection control procedures currently 
in place, with the aim of providing enhanced hygiene and a safer patient environment.  This review provides a discussion of a 
number of the key technologies currently under development for this purpose. 
2.  Gaseous Decontamination Methods 
 
The use of gaseous decontaminationDOVRNQRZQDVµFKHPLFDO-IRJJLQJ¶ within clinical settings has emerged as an adjunct measure for 
inactivation of microorganisms. Gaseous decontamination is a method where either a mist or vapour form of a chemical disinfectant is 
applied to promote whole room decontamination. Most typically the use of hydrogen peroxide, chlorine dioxide, and ozone have been 
investigated due to their broad antimicrobial spectra. 
 
Gaseous decontamination presents advantages including the dissipation of gaseous disinfectants allowing decontamination of large, 
difficult to reach areas, which may be missed or neglected by manual cleaning [12]. However despite this, several limitations are 
associated with this method of decontamination, particularly the rapid recontamination of rooms within days of re-occupancy, 
therefore making them more suited to terminal cleaning procedures to provide a deep-clean of the room before the next patient is 
admitted.  A range of gaseous technologies will be discussed in the following sections, and Table 1 provides a summary of the 
advantages and considerations of the use of gaseous technologies, and the other technologies discussed later in this review. 
2.1 Hydrogen Peroxide 
Hydrogen peroxide (H2O2) is an oxidizing agent used to decontaminate surfaces and objects within hospital rooms and 
wards. H2O2 has a broad spectrum of activity against clinically-relevant bacteria, bacterial endospores and viruses [15-
19], and once decomposed, does not pose any toxic threat to the environment by forming non-toxic by-products of water 
and oxygen [20]. The mechanism of antimicrobial activity is thought to involve oxidative damage to DNA, proteins and 
membrane lipids by free hydroxyl and ferryl radicals [15,20].  There are two distinct types of H2O2 delivery system: 
aerosolized systems make use of dry mist hydrogen peroxide and are known as aerosolized hydrogen peroxide (aHP) or 
dry mist hydrogen peroxide (DMHP), and, those which produce H2O2 vapour are usually referred to as vaporised 
hydrogen peroxide (VHP) or hydrogen peroxide vapour (HPV) [21]. 
Aerosolized systems include the commercially-available ASP Glosair (formally known as Sterinis) and Oxypharm 
Nocospray.  These systems deliver a pressure-generated fine mist aerosol of H2O2, and the recommended dose for 
hospitals is 6 ml/m3 per cycle, during which electrically charged particles circulate in the air, adhere to microbes in the 
air and on surfaces, inactivating them [15,16].  Following the decontamination cycle, no aeration systems are required to 
remove the H2O2 as it naturally decomposes (unlike H2O2 vapour systems) [21]. 
Clinical testing has proved successful, with a study by Barbut et al. [15] demonstrating the ability of aHP to 
decontaminate surfaces in hospitals.  There was a 91% decrease in contamination of various surfaces within hospital 
rooms previously occupied by a C. difficile infected patient, compared to a 50% decrease using conventional cleaning 
with 0.5% sodium hypochlorite [15].  More recently the efficacy of an aHP system was tested against clinical isolates 
from American hospital patients, and >3-log10 reductions of the microorganisms were achieved [22]. The authors 
concluded that these results indicate that aHP could be beneficial in the clinical setting and, due to its ease of use, its low 
cost, and the fact that the aerosol
 
decomposes naturally, may make it easier to use than HPV [15,22] 
Despite some beneficial features of aHP, HPV has generally been found to have greater efficacy against a range of 
nosocomial pathogens.  Fu et al. [23] demonstrated that HPV had greater efficacy and diffusion than aHP and achieved at 
least 2-log10 greater inactivation of C. difficile, MRSA and A. baumannii over and above the level of inactivation 
achieved using aHP.  The vapour systems generate a 30-35% w/w vapour of hydrogen peroxide through a high-velocity 
air stream, with a dose of 10 g/m3 recommended per cycle [16,23].  Well-documented vapour systems include Steris 
VHP and Bioquell HPV, with other systems including PEA Hydrogen Peroxide Gas Generator and Hygiene Solutions 
IC4 system. The Steris VHP system produces non-condensing vaporized hydrogen peroxide, at a constant concentration, 
which does not condense onto surfaces as the air is continually dried [16,24]. In contrast, the Bioquell system fills the air 
with hydrogen peroxide vapour, and the vapour subsequently condenses onto surfaces [16].  Both systems are controlled 
remotely from outside the room and unlike aHP, HPV systems have an aeration unit, as active catalytic conversion is 
required to aid decomposition of the hydrogen peroxide into non-toxic by-products [18]. 
Boyce et al. [25] documented the significant reduction in incidence of C. difficile associated disease (CDAD) due to HPV 
terminal cleaning. Comparing the acquisition of CDAD when the epidemic strain NAP1 was present, the study 
demonstrated a 53% decrease in cases after implementation of this technology for terminal cleaning [25]. More recently 
it has been shown that the use of HPV for decontamination of rooms previously occupied by a patient infected with, or 
carrying, a multidrug-resistant organism (MDRO), reduced the risk of the next occupant acquiring a MDRO by 64% 
[26]. Furthermore Chmielarczyk et al. [27] found the use of HPV could control an outbreak of A. baumannii in 
conjunction with good infection control practice, demonstrating the benefit of hydrogen peroxide vapour used during 
outbreaks. 
Several other considerations should be taken into account before the implementation of H2O2 technologies for terminal 
room decontamination. H2O2 has wide antimicrobial efficacy, however recent data suggests that Geobacillus 
stearothermophilus spores, which are used as a biological indicator of system efficacy, proved easier to inactivate than 
MRSA, therefore possibly indicating that the assumed microbial efficacy of H2O2, due to inactivation of a biological 
indicator, may not be automatically transferred to other organisms, and further testing may be required to establish the 
efficacy of H2O2 against clinical samples [28].  In terms of practical application, H2O2 is toxic to patients and staff, so 
rooms need to vacated, which can be impractical when wards have high bed occupancy rates, and treatment takes far 
longer than standard cleaning [21,29].  H2O2 toxicity also means that rooms must be sealed during use to prevent leakage 
of chemicals into the occupied environment [23].  Staff training is important to ensure correct use of the systems, as the 
equipment has to be carefully placed, especially in the case of aHP, to ensure optimal surface contact [12,21], and hand-
held monitors are also required to ensure no H2O2 leakage out of the room during decontamination, and that, within 
rooms, post-treatment levels of H2O2 are below health and safety limits [12,21].  Alongside this, it is important to note 
that Hardy et al. [30] found that after H2O2 vapour decontamination hospital rooms can become quickly re-contaminated 
with MRSA, therefore although beneficial as a terminal clean, post-use, rooms once again become contaminated and 
pose a risk to patients.  
2.2 Chlorine Dioxide 
Chlorine dioxide is an Environmental Protection Agency (EPA) registered sterilizer, which is being increasingly 
investigated as a method of clinical decontamination. Previous research has demonstrated the use of ClO2 for whole 
facility decontamination, with gaseous ClO2 utilised for decontamination in the wake of a Bacillus anthracis attack on a 
federal building in 2001 [31]. Much in vitro work has demonstrated extensive antimicrobial properties, with laboratory 
studies highlighting bactericidal and fungicidal properties [32]. A study by Wilson et al. [33] demonstrated complete 
inactivation of Stachybotrys chartarum, Penicillium chrysogenum, and Cladosporium cladosporioides fungal spores (6 
log10 population) following 24 hours treatment, demonstrating 100% treatment efficacy at both 500ppm and 1000ppm. 
Similarly another study highlighted significant reductions of Bacillus spores, with between 2.7 and 5.9 log10 reductions 
recorded depending on the exposed surface material [34]. 
Currently there are limited studies investigating the use of ClO2 for whole room decontamination. A recent study by 
Lowe et al [35] investigated decontamination of a hospital room. A selection of common nosocomial bacterial species 
were transferred onto 10 sites throughout the hospital room and the room was sealed to prevent gas leakage. Following 
six cycles of ClO2, results demonstrated between 7-10-log10 reductions of all bacteria tested.  
Despite extensive antimicrobial properties, a number of significant limitations have been associated with ClO2 gas 
including explosive properties, thus limiting commercial storage. Furthermore the ability to degrade and discolour certain 
materials limits whole room applications. Also logistic problems are also a major concern, since rooms need to be 
vacated and securely sealed to ensure no patient or staff exposure, due to the potential for ClO2 to cause respiratory 
irritations. 
2.3 Ozone 
Ozone is a strong oxidizing agent used for inactivation of vegetative bacterial cells, however it has shown less efficacy 
against resilient bacterial spores and fungi [12,36,37]. Despite extensive in vitro research, there are only a limited 
number of studies investigating ozone within clinical environments. 
A study by Doan et al. [38] compared the efficacy of 8 disinfection technologies, including ozone, for decontamination 
of hospital isolation rooms contaminated with C. difficile. Empty isolation rooms were manually cleaned and artificially 
contaminated with C. difficile spores, however results demonstrated only a 1.3-log10 reduction following treatment with 
25ppm ozone for 142 minutes.  
In order to enhance the antimicrobial efficacy of ozone, increased concentrations are required. However this poses a 
significant toxicity hazards and potential risk of respiratory irritation. Whilst the use of ozone has been described as a 
relatively cheap method of decontamination, Doan et al [38] evaluated the cost of multiple decontamination methods, 
highlighting ozone as the most expensive, at £116 per use, therefore ozone generation would need to be made more cost-
effective before it can be utilised widely throughout clinical environments.  
2.4 Steam Cleaning 
The use of steam cleaning within hospital settings has generated much interest over recent years, with efficacy 
demonstrated against a wide spectrum of nosocomial pathogens [12,39,40]. Steam can be used as an alternative to 
chemical disinfection where disadvantages include human hazard, microbial resistance and extensive treatment times. 
Steam cleaning, as with most other decontamination technologies presents limitations, such as steam dissipating into 
water presenting problems with electrical machinery and slip hazards [12,39]. However a recent study by Tanner et al 
[39] demonstrated the use of saturated steam cleaning. This method provides hotter but drier steam meaning it does not 
pose issues with decontamination of electronic based equipment. However increased temperature does introduce 
potential scalding hazards, consequently, increased precaution should be exercised. 
Following artificial inoculation onto sample surfaces, results demonstrated complete inactivation of a range of bacteria, 
fungi and viruses following only 5 seconds treatment [39]. A later study by Sexton et al [40] investigated the reduction of 
microbial load in 4 separate hospital rooms following treatment with a portable saturated steam vapour system, with 
results demonstrating up to 2-log10 reduction following only 10-20 seconds treatment. Although extensively employed 
within clinical settings further in situ studies are required to evaluate the efficacy of this system for viral and fungal 
decontamination. 
3. Light-based Decontamination Methods 
The widespread germicidal properties of light, specifically ultraviolet (UV) light, have long been known, and UV germicidal 
irradiation (UVGI) has been successfully utilised for various clinical antimicrobial applications.  The most germicidal 
wavelengths of light fall within the UVC region (240-260 nm), and UVC has traditionally been used for disinfection, particularly 
for air and medical device decontamination applications [41-42].  UVC light has extremely broad antimicrobial activity, 
inactivating bacteria, endospores, fungi and viruses, with its action due to the absorption of UV-C photons by DNA and RNA 
base pairs, which subsequently causes the formation of thymine dimers and other mutations, halting microbial replication [43-45]. 
More recent advancements in light technologies for infection control have involved the clinical application of continuous and 
pulsed UV light IRU µZKROH URRP¶ GHFRQWDPLQDWLRQ, and also the increasing knowledge and application of the antimicrobial 
properties of violet-blue visible light.  Details of these technologies are provided below. 
3.1 Continuous UV-Light for Whole-Room Decontamination 
Decontamination using continuous UVC-light typically uses systems which employ either a monochromatic low-
pressure mercury lamp at 254 nm or a polychromatic medium-pressure mercury lamp.  UVC-light has extensive 
antimicrobial properties, with bacteria, fungi, viruses and protozoan organisms all demonstrating susceptibility, and this 
broad, efficient action has led to the selection of UV-C for use in many decontamination systems [41,42,46,47]. There 
are currently several commercially available continuous UV-C devices undergoing clinical trials for hospital 
decontamination, many of which are automatic non-touch disinfection systems, ensuring operator safety.  
One such system is the Tru-D SmartUVC Room Decontamination device which utilises continuous-wave UV-light (CW-
UV) (254nm range) to eradicate pathogens. This device is activated by a wireless remote control with motion sensing 
technology and delivers a dose between 12,000 µWs/cm2 and 36,000 µWs/cm2 for destruction of vegetative and bacterial 
spores, respectively [21,46]. The device is placed in the centre of the room and operators control the technology 
wirelessly from an external location. Several studies have investigated the efficacy of Tru-D UV-C for disinfection of 
various nosocomial pathogens within the laboratory and clinical environment. Boyce et al. [47] reported a 1.7-2.9 log10 
reduction in C. difficile spores following inoculation onto stainless steel carrier disks. A further study demonstrated a 
dose-dependent 2-4 log10 reduction of MRSA, C. difficile and VRE using the same system [46].  Towards application for 
terminal cleaning, it was reported that following traditional terminal cleaning of a room after discharge of MRSA 
positive patients, 18% of site tested positive for MRSA; however, following Tru-D disinfection, this was reduced to 0% 
[46]. 
3.2 Pulsed UV-Light for Whole-Room Decontamination 
Recent work has focused on the use of pulsed, polychromatic xenon flashlamps for microbial inactivation, as this 
technology enables rapid energy delivery and wide antimicrobial activity, whilst being more environmentally friendly 
than CW-UV lamps as they do not contain mercury [48-50].  Using this technology, Xenex has developed fully-
automated robotic decontamination systems for clinical room decontamination applications, and have been marketed as 
µGerm Zapping Robots¶3XOVHG[HQRQ893;-UV) emits intense broad spectrum light, rich in UV-C wavelengths in 
short, high energy pulses, providing rapid decontamination, much faster than that achieved with continuous UV-light. 
This device has a sporicidal setting of 5 minutes in each position, with a typical patient room taking 3 positions. The PX-
UV system produces a pulsed flash at a frequency of 1.5 Hz with an approximate output of 505 J per pulse and a pulse 
duration of less than 360µs [51]. Clinical testing has demonstrated that, when combined with terminal cleaning, the PX-
UV disinfection system had the ability to achieve a 100% reduction in positive cultures of VRE [52]. Furthermore, a 
recent study by Levin and colleagues reported that three 7-minute exposures of PX-UV following terminal cleaning 
contributed to a 53% reduction in the hospital acquired C. difficile infections [51]. 
Overall, when looking at both pulsed and continuous UVC decontamination technologies, it can be seen that they offer a 
number of potential advantages, including their reliability and ease of usability, and importantly, the rapid biocidal 
activity of UVC against a wide range of healthcare-associated pathogens.  However, as is the case with the chemical-
based technologies, UVC technologies are also restricted for use for terminal cleaning of vacated rooms due, in this case, 
to the carcinogenic and mutagenic nature of UVC-light [53].  Additionally, with UV-technologies, there is a limited 
capacity to decontaminate larger rooms due to light dissipation; similarly as many objects may be out-with the direct line 
of site, reduced inactivation on indirectly exposed sites may be experienced [54], therefore multiple cycles must be 
conducted, leaving system operation open to potential human error, as operators must choose appropriate locations 
thereby requiring more operator time. An issue for future consideration is the degradative effects of long-term UVC-
exposure on hospital materials and equipment.  This is largely unknown and has not yet been evaluated, however the 
degradative properties of UV-light on plastics and other materials is widely recognised [55].  
3.3 405nm Violet-Blue Light 
More recently, the germicidal properties of violet-blue visible light wavelengths have been demonstrated, and the 
enhanced safety of these wavelengths compared to UV-light, are paving the way for its exploitation as an alternative 
light-based environmental decontamination technology. 
The high-intensity narrow-spectrum (HINS) light environmental decontamination system (EDS) is a visible light based 
system which uses low-irradiance violet-blue light, focused on 405nm, to provide continuous environmental 
decontamination, a technology that was recently reviewed [56].  Unlike, UVC and chemical-based systems, the EDS is 
designed for use in occupied environments, providing continuous decontamination of the air and all exposed surfaces in 
occupied environments.  Although not yet commercially available, this user-friendly, ceiling-mounted light source has 
been evaluated within clinical environments with successful results [57-59].   
Studies have investigated use of the system within occupied isolation rooms, and results, generated from the collection of 
environmental samples before, during and after use of this technology, have provided significant evidence of the efficacy 
of this system for reducing environmental bioburden around isolation rooms.  Studies carried out in an occupied ICU 
isolation room, demonstrated evidence of the efficacy of the EDS, with a significant 60 to 70% reductions in both the 
total viable bacterial counts (TVC) and the staphylococcal bioburden around the environment, over and above the 
reductions achieved by cleaning alone, with the EDS achieving an almost uniform reduction in bioburden across the 
room surfaces [59].  Studies conducted in Burns Unit isolation rooms also demonstrated the efficacy of the system, with 
56±86% reductions in staphylococcal contamination on surfaces around isolation rooms occupied by MRSA positive 
patients, and up to 90% reduction of contamination after 24h use in an unoccupied room [57].  Further confirmation of 
the effectiveness of the system was obtained by switching off the EDS and observing that bacterial contamination levels 
increased and returned to around pre-treatment levels when operation of the system ceased.  In addition to its use for 
disinfection of occupied isolation rooms, a study by Bache et al [58] demonstrated the efficacy of the system for 
decontamination of a Burns outpatient clinic, with a 61% efficacy achieved.  Results have also demonstrated its efficacy 
for significantly reducing the environmental microbial contamination of non-patient environments including a nurses 
changing area [60]. 
The antimicrobial action of 405nm violet-blue light is caused by oxidative damage resulting from the photo-excitation of 
porphyrin molecules within exposed microorganisms, and antimicrobial activity is broad, affecting a wide range of 
clinically-relevant organisms, including MRSA, C. difficile, and A. baumannii [61].  Bacteria, bacterial biofilms, fungi, 
yeast and bacterial endospores are all susceptible to inactivation, however, as expected, bacterial spores display resilience 
and require significant doses of light to initiate inactivation [62-64].  The virucidal effects of this technology are also not 
fully determined, however initial studies using bacteriophage highlight that inactivation is possible, however, as with the 
spores, higher light doses are required [65]. 
As mentioned, a major benefit of this technology is that it can be used safely within occupied environments, and this is 
due to the use of visible light wavelengths, with a lower photon energy than that of UVC-light.  However, with this 
benefit, comes the inherent limitation that inactivation using this low irradiance light is much slower than that of UVC-
light, requiring exposure times in the order of hours [66] rather than minutes, as is the case with most of the UV and 
chemical-based systems.  This however, means that the system is optimally deployed for continuous decontamination 
where it can continuously impact on the release of microbial pathogens associated with major bioburden dispersal 
activities such as bandage changing and bed-making [67], rather than for intense, short-time terminal cleaning.  An 
additional benefit resulting from the use of these longer, lower energy photons, is that there will be significantly less 
material degradation compared to the UV and chemical-based systems [55].  
 
4. Conclusions 
HAI resulting from cross-transmission of infectious organisms from the environment is an area gaining increased recognition, and 
with the appropriate level of patient care, and enhanced environmental cleaning, rates of these infections from environmental 
sources have the potential to be minimised.  For various reasons, ranging from staff time constraints to the fact that not all 
surfaces around the patient environment are regularly cleaned, a new range of technologies are emerging which focus on 
SURYLGLQJ GHFRQWDPLQDWLRQ RI WKH µZKROH-URRP¶ HQYLURQPHQW  7KLV UHYLHZ KDV GHVFULEHG D UDQJH RI ERWK FKHPLFDO-based and 
light-EDVHGµZKROH-URRP¶GHFRQWDPLQDWLRQ technologies, including hydrogen peroxide, chlorine dioxide, ozone, steam, UV-light 
and violet-blue light.  These technologies each present benefits, ranging from rapid action to the safe decontamination of occupied 
patient areas, however each technology also has limitations which need to be taken into consideration before implementation. 
Although these technologies are being developed for providing enhanced environmental hygiene, they are not a replacement for 
traditional disinfectant-based cleaning, and it is extremely important that cleaning and infection control procedures are still 
maintained to the highest standard.  For a number of these technologies, efficacy is significantly reduced if there is biological 
soiling or debris present on surfaces [68,69], therefore reinforcing the strict requirement for traditional cleaning, even when used 
in combination with new technologies, and these considerations will be very important during the uptake of these technologies.  
Overall, there is unlikely to be a single solution to ensuring the cleanest possible patient environment, but the best method is 
likely to involve complementary use of a number of strategies.  For example, the use of routine disinfectant cleaning could be 
supplemented by use of violet-blue light for continuous room decontamination, and chemical or UV-light based terminal cleans, 
thus providing effective decontamination before, during and after the patient stay.  This type of multi-faceted decontamination 
strategy, coupled with optimal hand hygiene compliance, is currently likely to be the best way forward for improved 
environmental decontamination and reducing the risk of patients contracting an HAI from environmental sources. 
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Table 1.  A summary of the advantage and considerations of a range of environmental decontamination technologies.  Manual disinfectant cleaning has been included for 
comparision. 
 
 
Disinfection Technology Operational Advantages Operational Considerations 
 
Traditional manual cleaning 
and disinfection 
 
x Required as integral part of hospital hygiene strategy for the 
removal of soil and for clean appearance of surfaces. 
x Wide antimicrobial efficacy 
x Ease of use 
x Standard accepted method of cleaning 
 
x Labour intensive with compliance issues.  
x Application is intermittent with variable frequency.  
x Only suitable and accessible surfaces are treated. 
x Air not treated; Fabrics and electronic equipment often not treated 
x Detergents can have limited antimicrobial effectiveness. 
x Disinfectants may be toxic and require special safety precautions. 
 
 
Gaseous disinfection /  
chemical fogging 
Includes: 
Chlorine dioxide (ClO2) 
Hydrogen peroxide (H2O2) 
Ozone (O3) 
 
x Wide antimicrobial efficacy 
x Rapid decontamination effect 
x The whole room (surfaces and air) is treated 
x Good for terminal/deep cleaning 
 
 
x Safety considerations require experienced operator supervision and training. 
x Involves use of toxic chemicals. 
x Patients and staff cannot be exposed. 
x Rooms require sealing and are out of commission during treatment. 
x Short term effect as high contamination levels return after several days. 
x Some materials can be damaged 
 
 
Steam cleaning 
 
 
x Wide antimicrobial efficacy 
x Rapid decontamination effect 
x Good for terminal/deep cleaning 
x Because the steam cleaning machines incorporate vacuum 
extraction, dirt, water and contaminants are removed from the 
area being cleaned. 
 
x Safety considerations require experienced operator supervision. 
x Not usable in presence of patients.  
x Disruptive to normal hospital routine. 
x Short term effect as high contamination levels return after several days. 
x Only suitable and accessible surfaces are treated. 
x Air is not treated and fabrics are not effectively treated. 
x Not compatible with sensitive electronic equipment. 
 
 
UV-light technology 
 
x Wide antimicrobial efficacy 
x Rapid decontamination effect 
x The whole room (surfaces and air) can be treated 
x Good for terminal/deep cleaning 
 
 
x Uses dangerous radiation and patients/staff cannot be exposed. 
x Room is out of commission during UV treatment. 
x Some materials can be damaged by photosensitive degradation. 
x If used intermittently, the decontamination effective is short term. 
x Microbial resistance to UV can develop. 
 
 
405nm HINS-light EDS 
 
 
x Safe for use in presence of patients and staff, and non-disruptive 
x Wide antimicrobial efficacy  
x Provides continuous disinfection of the environment (air, 
exposed surfaces, fabrics, electronic equipment.) 
x Continuous use provides decontamination during periods of 
heavy microbial dispersal (e.g. bed-making, bandage changing) 
x Automated system with no compliance/training problems.  
x Environmentally and material friendly / no chemicals involved. 
x Uses energy efficient LED technology with low maintenance 
requirements 
 
 
x Decontamination effect is slower than with chemical/UV-based systems 
x Spores require high doses for inactivations 
x Full virucidal efficacy has not yet been established 
x Most effectively used for continuous disinfection rather than for rapid 
terminal/deep cleaning applications 
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